key: cord-0789648-ov0mr64v authors: A. R., Mehdizadeh; J. J., Bevelacqua; S. A. R., Mortazavi; S. M. J., Mortazavi title: COVID-19: Introducing Low Dose Radiation as an Effective Treatment for Pneumonia that Shouldn’t Induce Selective Pressure and New Mutations date: 2020-06-01 journal: J Biomed Phys Eng DOI: 10.31661/jbpe.v0i0.2005-1114 sha: 4f77aea73fc06567d4abf3ab8fe5ec584e4d46ff doc_id: 789648 cord_uid: ov0mr64v nan These investigators proposed a modified effective method for managing pneumonia in COVID-19 patients with the minimal negative effects. In their proposed method, patients should receive a single dose of either 100, 180 or 250 mGy X-ray after a pre-exposure to a conditioning dose. However, it is an open issue if lung irradiation has all the immune system stimulation advantages of a whole-body irradiation. These investigators also addressed the advantages of LDR over treatment methods such as those use antiviral drugs. They raised the concerns over unintentional shift of the SARS-CoV-2 to more resistant types. Now, we know that when the treatment is not effective and viral genome replicates, selective pressure leads the virus to rapid adaptation toward resistance "An increasing number of viral infections that impair host health are treated using antiviral drugs, typically targeting mechanisms of viral replication. If the treatment is robust and viral fitness is impaired sufficiently, no viral genomes will be successfully replicated, but if treatment is not as effective and some genomes replicate, selective pressure may result in rapid adaptation toward resistance" [7] . Ghadimi-Moghadam et al. [6] noted that LDR not only has the capacity of modulating excessive inflammatory responses, but regulates the lymphocyte counts, and controls bacterial co-infections in patients with COVID-19. LDR mitigates inflammation and facilitates healing via the polarization of macrophages to an anti-inflammatory or M2 phenotype [8] . Moreover, inducing apoptosis in radiosensitive neutrophils and activated T cells, and inhibiting endothelial/ leukocyte interaction resulting in reduced trafficking of infiltrating immune cells are additional proposed mechanisms by which LDR mitigates inflammation and facilitates healing. Given this consideration, a single dose of either 100, 180 or 250 mGy of X-rays cannot exert a significant selective pressure on SARS-CoV-2, and hence does not lead the virus to "accelerated evolution" through mutations. LDR uses its capacity of modulating excessive inflammatory responses, regulates lymphocyte counts, and controls bacterial co-infections in patients with CO-VID-19. Just a short time after this publication, the potential of low dose radiation therapy as a treatment for COVID-19 pneumonia received attention globally. Canadian scientists from the Universities of Calgary and Alberta published a letter and suggested that despite some obstacles (e.g., existing strain on radiotherapy resources and separating COVID-19 patients and cancer patients), conducting clinical trials to further investigate the efficacy of whole lung low dose radiation therapy (LDRT) would present a very low risk treatment for COVID-19 pneumonia patients. They stated that LDRT has the potential to reduce mortality and alleviate COVID-19 related strains on healthcare systems [9] . Subsequently, Spanish [10] [11] , French [12] [13] , American [14] , German [15] and Indian [16] scientists also addressed the importance of LDRT in these treatments. Now a paper published in the Lancet [17] raises the question whether anticancer radiation therapy may have protective role against the cytokine storm caused by SARS-CoV-2? Moreover, a literature search shows that groups of scientists from different parts of the world have also planned for conducting relevant experiments. Moreover, new reports show that COVID-19 cannot be considered a standard variety, contagious and lethal respiratory disease with no vaccine and no treatment, but also a real threat to kidneys, heart, intestines, liver and brain. Storms of blood clots have been reported in some hospitalized patients with COVID-19 [18] . Studies show that clots occur in 20-30% of terminally ill COVID-19 patients [19] [20] . Given this consideration, a main question is if LDRT can reduce the occurrence of blood clots? Considering the point that oxidative stress plays an important role in clotting of blood through mechanisms such as enhanced generation of isoprostanes [21] , it can be hypothesized that LDRT would decrease or block the clotting of blood through reducing oxidative stress. This mechanism would require low-dose radiation for the whole body, not just to the lungs. Well-designed studies are needed to evaluate the validity of this hypothesis. There are additional open issues that merit future investigation. In particular, physicians and scientists remain unsure regarding the specific effects of LDR on inflammation and how it is mitigated by various irradiation-based treatment modes. In spite of these uncertainties, low dose irradiation provides a possible beneficial treatment protocol to alleviate COVID-19 related strains on healthcare systems. Patient-derived mutations impact pathogenicity of SARS-CoV-2. medRxiv NIH Publishes COVID-19 Treatment Guidelines Stopping the spread of COVID-19 Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy How radiotherapy was historically used to treat pneumonia: could it be useful today? COVID-19 tragic pandemic: concerns over unintentional "directed accelerated evolution" of novel Coronavirus (SARS-CoV-2) and introducing a modified treatment method for ARDS Antiviral drug resistance as an adaptive process Molecular and epigenetic basis of macrophage polarized activation. Seminars in immunology Is low dose radiation therapy a potential treatment for COVID-19 pneumonia? Radiotherapy and Oncology Low dose lung radiotherapy for COVID-19 pneumonia. The rationale for a cost-effective anti-inflammatory treatment Low-dose radiation therapy: could it be a game-changer for COVID-19? Irradiation pulmonaire ā faible dose pour l'orage de cytokines du covid-19: pourquoi pas? Cancer Radiother Low doses of radiation therapy increase the immunosuppressive profile of lung macrophages via IL-10 production and IFNγ/IL-6 suppression: a therapeutic strategy to counteract lung inflammation? Low dose radiation therapy as a potential life saving treatment for COVID-19-induced acute respiratory distress syndrome (ARDS). Radiotherapy and Oncology Low-dose radiation therapy for COVID-19 pneumopathy: what is the evidence? Breakthrough of COVID-19 using radiotherapy treatment modalities COVID-19 and LDR-Based Treatment Cancer and COVID-19: what do we really know? The Lancet Coronavirus blood-clot mystery intensifies Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis Pulmonary embolism in COVID-19 patients: awareness of an increased prevalence Platelet oxidative stress and thrombosis COVID-19: Introducing Low Dose Radiation as an Effective Treatment for Pneumonia that Shouldn't Induce Selective Pressure and New Mutations None